20491 ⎘
Medicinal preparations containing organic active ingredients Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
Sub-classes:12-LIPOXYGENASE INHIBITORS FOR THE TREATMENT OF LUPUS
#2DUAL INHIBITORS FOR HDAC3 AND HIV-1 PR
#3COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS
#4COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#5SMALL MOLECULE ANTAGONIST TO PACAP RECEPTOR AND USES THEREOF
#6REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA
#7METHODS FOR TREATING HAIR LOSS DISORDERS
#8REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION
#9COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#10POTENTIATION OF HELMINTH TREATMENT
#11COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#12COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#13Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides
#14COMPOSITION AND TREATMENT FOR CANCER WITH MUTATIONS
#15COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#16COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#17Methods for treating hair loss disorders
#18ACCELERATING THE DRYING RATE OF SOFTGEL CAPSULES
#19Methods for treating hair loss disorders
#20Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
#21N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANT
#22Naphthalenesulfonamide compound, preparation method, and application
#23INJECTABLE CLORSULON COMPOSITIONS, METHODS AND USES THEREOF
#24TARGETING NAD BIOSYNTHESIS IN THE TREATMENT OF CANCER
#25PHARMACEUTICAL COMBINATION OF WNT SIGNALING AND MACC1 INHIBITORS
#26METHOD OF PREVENTING OR TREATING TREATMENT-INDUCED GASTROINTESTINAL INJURY
#27THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
#28REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA
#29Potentiation of helminth treatment
#30METHODS OF TREATING THROMBOSIS
#31METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE
#32Inhibitors of RAC1 and uses thereof for inducing bronchodilatation
#33METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#34Antiviral agents for drug-resistant influenza A
#35INJECTABLE PHARMACEUTICAL COMPOSITION CONTAINING MELOXICAM, AND PREPARATION METHOD THEREFOR
#36Methods for treating hair loss disorders
#37COMBINED MEDICINAL PREPARATION FOR TREATING VIRAL INFECTIONS
#38PHARMACEUTICAL NANOSUSPENSION FOR THE THERAPY OF HIV INFECTION
#39COMBINATION THERAPIES COMPRISING IMMUNO-ONCOLOGY AGENTS AND BELINOSTAT
#40METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#41Use of (benzenesulfonamido) benzamide compounds for inhibiting liver fibrosis
#42Methods of treating acute kidney injury
#43Therapeutic compounds and methods of use thereof
#44Methods for treating hair loss disorders
#45METHOD FOR PREPARING PRODUCT BASED ON LEAVES OF THE SEDUM TELEPHIUM PLANT FOR THE TREATMENT OF NAILS INFECTED WITH ONYCHOMYCOSIS
#46COMPOSITIONS TARGETING SENESCENT CELLS AND THE USES THEREOF
#47Use of adenosine receptor signaling to regulate P-gp function
#48Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists
#49Antiviral agents for amantadine-resistant influenza A
#50METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#51Use of (benzenesulfonamido) benzamide compounds for inhibiting liver fibrosis
#52Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genes
#53Cancer therapy with a parvovirus combined with a BCL-2 inhibitor
#54Methods for treating hair loss disorders
#55Methods for Modulating Genome Editing
#56Method for treating recurring skin and mucous membrane diseases caused by HSV-1 and HSV-2
#57SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA
#58METHODS FOR TREATING A NEUROLOGICAL DISORDER IN A SUBJECT USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) PROYL HYDROXYLASE
#59Drug with activity against the herpes virus family
#60METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#61Small molecule efflux pump inhibitors
#62Compositions and method for treatment and prophylaxis of inflammatory bowel disease
#63Sulfonamide compounds for inhibition of metastatic tumor growth
#64LKB1 related diagnostics and treatments of cancer
#65Methods for treating hair loss disorders
#66Methods for treating hair loss disorders
#67ANTIVIRAL DRUGS FOR TREATMENT OR PREVENTION OF DENGUE INFECTION
#68Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms
#69Treatment and/or prevention of bone metastasis
#70Compositions Associated with and Methods of Managing Neutrophil Movement
#71COMPOSITION FOR PREVENTING OR TREATING MUSCULAR ATROPHY OR PROMOTING MUSCULAR REGENERATION IN SUBJECT COMPRISING SULFONAMIDE COMPOUND AND USE THEREOF
#72Method for treating recurring skin and mucous membrane diseases caused by HSV-1 and HSV-2
#73Pharmaceutical composition for treating disease associated with demyelination of neurons and method of using the pharmaceutical composition
#74Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor
#75Methods for treating hair loss disorders
#76Methods for treating hair loss disorders
#77Antiangiogenic small molecules and methods of use
#78Compositions and method for treatment and prophylaxis of inflammatory bowel disease
#79Combinations of Oral Medicaments Bonded by a Wrapping
#80Beta-3 adrenoceptor agonists for the treatment of pulmonary hypertension
#81Enzyme inhibitors
#82Pharmaceutical composition for treatment of HIV infection
#83METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#84Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methods
#85Small molecule inhibitors of viral protein interactions with human t-RNA
#86Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses
#87Vitamin D receptor agonists and uses thereof
#88Tetrahydrobenzothiophene compound
#89Methods to treat infections
#90Carbonic anhydrase IX-related markers and use thereof
#91Combinations of kinase inhibitors for the treatment of cancer
#92Foamable suspension gel
#93COMPOUNDS AND METHODS FOR MODULATING MITOCHONDRIAL METABOLISM AND REACTIVE OXYGEN SPECIES PRODUCTION
#94Methods for treating hair loss disorders
#95Sulfonamides as HIV protease inhibitors
#96Drug with activity against the herpes virus family
#97Foamable suspension gel
#98Efficacy in treating bacterial infections
#99Sulfonamide compounds for inhibition of metastatic tumor growth
#100Composition and method for compounded therapy
#101Composition and method for compounded therapy
#102Pharmaceutical compositions of co-crystals of tramadol and coxibs
#103Tetrahydrobenzothiophene compound
#104ABA Receptor Agonists for Increased Plant Stress Resistance
#105TETRAHYDROBENZOTHIOPHENE COMPOUND
#106Combination Therapy Comprising A CCR5 Antagonist, A HIV-1 Protease Inhibtior and a Pharmacokinetic Enhancer
#107PHARMACEUTICAL KIT FOR TREATING NEURONAL DAMAGES
#108Compositions and method for treatment and prophylaxis of inflammatory bowel disease
#109Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type II diabetes
#110Antimicrobial material and method for making the same
#111Methods for improving kidney function
#112Antiangiogenic small molecules and methods of use
#113COMPOSITION FOR REGULATING CELLULAR SENESCENCE COMPRISING [N-2-(CYCLOHEXYLOXYL)-4-NITROPHENYL]-METHANESULFONAMIDE
#114Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#115Methods of Treating an Overweight or Obese Subject
#116Foamable suspension gel
#117Halo active aromatic sulfonamide organic compounds and uses therefor
#118Halo active aromatic sulfonamide organic compounds and uses therefor
#119STABLE CLEANSER COMPOSITIONS CONTAINING SULFUR
#120Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
#121Stabilization of hypoxia inducible factor (HIF) alpha
#122COMPOSITION FOR CONTROL OF AGING AND/OR EXTENSION OF LIFE, CONTAINING DAPSONE AS ACTIVE INGREDIENT
#123Use of COX-2 Inhibitors for the Treatment of Schizophrenia, Delusional Disorders, Affective Disorders, Autism or Tic Disorders
#124NPY Y5 ANTAGONIST
#125Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#126Combination of Oral Medicaments Bonded by a Wrapping
#127Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#128COMPOSITION AND METHOD FOR TREATING ACNE
#129NPY Y5 antagonist
#130Treating alzheimer's disease and osteoporosis and reducing aging
#131Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#132USE OF VITAMIN PP COMPOUNDS
#133Antiviral drugs for treatment or prevention of dengue infection
#134COMPOSITION FOR REGULATING CELLULAR SENESCENCE COMPRISING N-[2-(CYCLOHEXY-LOXYL)-4-NITROPHENYL]-METHANESULFONAMIDE
#135Compositions and methods for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related neurological diseases
#136COMPOSITION COMPRISING A DIURETIC AND A CARDIAC GLYCOSIDE FOR THE TREATMENT OF DNA VIRAL INFECTIONS OF THE EYE
#137Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#138Methods of inhibiting bacterial virulence and compounds relating thereto
#139Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
#140Halo active aromatic sulfonamide organic compounds and odor control uses therefor
#141NEW METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
#142Antibiotic combinations for providing total solution to the treatment of infections
#143Treatment Of Lower Urinary Tract Dysfunction With CB2-Receptor-Selective Agonists
#144Combination of at least two 5HT6-Ligands
#145Solvent systems for pour-on formulations for combating parasites
#146Methods for treating glioma
#147CRTH2 Receptor Ligands For Therapeutic Use
#148Stable cleanser compositions containing sulfur
#149Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations
#150Antibiotic product formulation
#151Chemical Compounds
#152ANTIALLERGIC AGENTS
#153Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
#154Novel Pharmaceutical Compositions
#155Drug for External Use and Adhesive Patch
#156Composition and method of treating peripheral neuropathy
#157Foamable suspension gel
#158Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye
#159Antiallergic agents
#160Antiallergic agents
#161Azithromycin for treatment of granulomatous rosacea
#162Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#163Phosphate transport inhibitors
#164NPY Y5 antagonist
#165Compounds and methods for treatment of cancer
#166Stabilization of hypoxia inducible factor (HIF) alpha
#167Stabilization of hypoxia inducible factor (HIF) alpha
#168Stabilization of hypoxia inducible factor (HIF) alpha
#169Cytoprotection through the use of hif hydroxylase inhibitors
#170Inhibitors of cdc25 phosphatases
#171Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor
#172Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy
#173Methods of increasing endogenous erythropoietin (EPO)
#174Methods of increasing endogenous erythropoietin (EPO)
#175Methods of increasing endogenous erythropoietin (EPO)
#176Methods and compositions for the treatment of psychiatric disorders
#177Inhibitors of Cdc25 phosphatases
#178Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases
#179Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations
#180Antiallergic
#181Antibiotic product formulation
#182Stable cleanser compositions containing sulfur
#183Stable cleanser compositions containing sulfur
#184System and method for generating an amalgamated database
#185Method of improved diuresis in individuals with impaired renal function
#186Method of improved diuresis in individuals with impaired renal function
#187Stable cleanser compositions containing sulfur
#188Halo active aromatic sulfonamide organic compounds and odor control uses therefor
#189Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
#190Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#191Terminological mapping
#192Sulfacetamide formulations for treatment of rosacea
#193Long-acting drug combinations for the treatment of respiratory complaints
#194Method of improved diuresis in individuals with impaired renal function
#195Topical burn cream